Energy metabolism transition in multi-cellular human tumor spheroids

✍ Scribed by Sara Rodríguez-Enríquez; Juan Carlos Gallardo-Pérez; Alejandro Avilés-Salas; Alvaro Marín-Hernández; Liliana Carreño-Fuentes; Vilma Maldonado-Lagunas; Rafael Moreno-Sánchez

• Publisher: John Wiley and Sons
• Year: 2008
• Tongue: English
• Weight: 150 KB
• Volume: 216
• Category: Article
• ISSN: 0021-9541
• DOI: 10.1002/jcp.21392

✦ Synopsis

Abstract

It is thought that glycolysis is the predominant energy pathway in cancer, particularly in solid and poorly vascularized tumors where hypoxic regions develop. To evaluate whether glycolysis does effectively predominate for ATP supply and to identify the underlying biochemical mechanisms, the glycolytic and oxidative phosphorylation (OxPhos) fluxes, ATP/ADP ratio, phosphorylation potential, and expression and activity of relevant energy metabolism enzymes were determined in multi‐cellular tumor spheroids, as a model of human solid tumors. In HeLa and Hek293 young‐spheroids, the OxPhos flux and cytochrome c oxidase protein content and activity were similar to those observed in monolayer cultured cells, whereas the glycolytic flux increased two‐ to fourfold; the contribution of OxPhos to ATP supply was 60%. In contrast, in old‐spheroids, OxPhos, ATP content, ATP/ADP ratio, and phosphorylation potential diminished 50–70%, as well as the activity (88%) and content (3 times) of cytochrome c oxidase. Glycolysis and hexokinase increased significantly (both, 4 times); consequently glycolysis was the predominant pathway for ATP supply (80%). These changes were associated with an increase (3.3 times) in the HIF‐1α content. After chronic exposure, both oxidative and glycolytic inhibitors blocked spheroid growth, although the glycolytic inhibitors, 2‐deoxyglucose and gossypol (IC~50~ of 15–17 nM), were more potent than the mitochondrial inhibitors, casiopeina II‐gly, laherradurin, and rhodamine 123 (IC~50~ > 100 nM). These results suggest that glycolysis and OxPhos might be considered as metabolic targets to diminish cellular proliferation in poorly vascularized, hypoxic solid tumors. J. Cell. Physiol. 216: 189–197, 2008. © 2008 Wiley‐Liss, Inc.